Innovation and night light in large and small cities. by Saul Estrin (8629173)

Subjects:

Geographical distribution of large cities and small cities. by Saul Estrin (8629173)

Subjects:

Data and code from: Continental declines in North American small mammal populations by Alec Medd (20968740)

Subjects:

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

Subjects:

Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

Subjects:

Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Largest changes in influenza vaccine rates, Pre- vs. Post-COVID-19. by Tyler B. Nofzinger (21560244)

Subjects:

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…To increase the thermal stability of standard aerogels comprising small full-density SiO₂ nanoparticles (SFPs) (typically 2–15 nm in diameter), SiO₂ aerogels were doped with large hollow SiO₂ nanoparticles (LHPs) with diameters of 100–250 nm. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…To increase the thermal stability of standard aerogels comprising small full-density SiO₂ nanoparticles (SFPs) (typically 2–15 nm in diameter), SiO₂ aerogels were doped with large hollow SiO₂ nanoparticles (LHPs) with diameters of 100–250 nm. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…To increase the thermal stability of standard aerogels comprising small full-density SiO₂ nanoparticles (SFPs) (typically 2–15 nm in diameter), SiO₂ aerogels were doped with large hollow SiO₂ nanoparticles (LHPs) with diameters of 100–250 nm. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…To increase the thermal stability of standard aerogels comprising small full-density SiO₂ nanoparticles (SFPs) (typically 2–15 nm in diameter), SiO₂ aerogels were doped with large hollow SiO₂ nanoparticles (LHPs) with diameters of 100–250 nm. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…To increase the thermal stability of standard aerogels comprising small full-density SiO₂ nanoparticles (SFPs) (typically 2–15 nm in diameter), SiO₂ aerogels were doped with large hollow SiO₂ nanoparticles (LHPs) with diameters of 100–250 nm. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…To increase the thermal stability of standard aerogels comprising small full-density SiO₂ nanoparticles (SFPs) (typically 2–15 nm in diameter), SiO₂ aerogels were doped with large hollow SiO₂ nanoparticles (LHPs) with diameters of 100–250 nm. …”

Why does task performance decrease with burst length? by Swathi Anil (17382903)

Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

Subjects:

CS rates increased with protraction and decreased with retraction. by Paul Hage (21071783)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”